Monday, 9 March 2009

Drug firms in $41bn giant merger

The pharmaceutical industry is one of the best examples on how market forces lead to consolidation and M&As.

Merck is to buy rival Schering-Plough in a $41.1bn (£29.4bn) deal, creating one of the world's biggest drug companies. The merger unites the makers of cholesterol drugs Zetia and Vytorin at a time of falling sales.

Read the whole the whole article at:

No comments: